← Back to Search

Aquatic Therapy for Cerebral Palsy

N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child with neuro-motor diagnosis (e.g., CP, hypoxia, etc.)
Children aged 3-9 years, and parents/guardians aged 18+
Must not have
Compromised airway
Uncontrolled seizures
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately after intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial studies the effectiveness of aquatic therapy for children 3-9 with neuromotor deficits, like cerebral palsy. Twice a week in a warm water pool for 10 weeks.

Who is the study for?
This trial is for children aged 3-9 with neuromotor issues like cerebral palsy or brain hypoxia, who have trouble using their arms and doing self-care tasks. Their parents or guardians must be over 18. Kids can't join if they have breathing problems or seizures that aren't under control.
What is being tested?
The study tests aquatic therapy in a warm pool, focusing on swim safety, improving arm use, and helping kids do everyday activities by themselves. It involves going to the pool twice a week for ten weeks.
What are the potential side effects?
Aquatic therapy is generally gentle but may include risks like minor injuries from slips or falls, muscle soreness from exercises, skin reactions to chlorine in the water, and fatigue after sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child has a diagnosis affecting their brain and muscle function.
Select...
I am a parent/guardian over 18 or a child between 3-9 years old.
Select...
My child has difficulty using their arms or hands.
Select...
My child struggles with daily self-care activities.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have trouble breathing due to a blocked airway.
Select...
I have seizures that are not controlled by medication.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediately after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately after the intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Pediatric Evaluation of Disability Index, Computer Adaptive Text (PEDI-CAT)
Change in Quality of Upper Extremity Skills Test (QUEST)
Change in Water Orientation Test Alyn (WOTA)
Secondary study objectives
Change in Canadian Occupational Performance Measure (COPM)
Change in Participation and Environment Measure (PEM-CY)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention: aquatic occupational therapy (AquOTic-NM)Experimental Treatment1 Intervention
aquatic occupational therapy 30 minutes, self care training 15 minutes

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
866 Previous Clinical Trials
655,121 Total Patients Enrolled
Franklin County Board of Developmental DisabilitiesUNKNOWN
1 Previous Clinical Trials
48 Total Patients Enrolled

Media Library

Aquatic therapy Clinical Trial Eligibility Overview. Trial Name: NCT05753345 — N/A
Aquatic therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05753345 — N/A
Anoxic Encephalopathy Research Study Groups: Intervention: aquatic occupational therapy (AquOTic-NM)
Anoxic Encephalopathy Clinical Trial 2023: Aquatic therapy Highlights & Side Effects. Trial Name: NCT05753345 — N/A
~0 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top